• PDF: Immediate delivery

Coagulation Factors
Competitor Analysis

  • Publication Date:January 2011
  • Publisher:La Merie
  • Product Type: Report
  • Pages:139

Coagulation Factors Competitor Analysis

The present Competitive Intelligence Report about Coagulation Factors provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation disorders as of January 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Global sales of the five major recombinant products of coagulation factors VIII, IX and VIIa in 2009 were US$ 5.5 bln. This attractive market size and the soon beginning expiration of basic patents stimulated established hemophilia product companies as well as companies with new technologies to enter the race for next generation systemic coagulation factor products. In fact, projects are rapidly progressing in clinical trials and the field is expected to become very competitive.

Apart from recombinant products, plasma-derived coagulation factors still play a considerable role, albeit bovine derived products are considerably being challenged by human recombinant and plasma-derivd products. Coagulation factors not only are being used for systemic treatment of hereditary coagulation factor deficiencies, but also for topical or systemic treatment of bleedings.

The report includes a compilation of current active projects in research and development of topical and systemic coagulation factors obtained by purification of human plasma or by recombinant DNA technology. In addition, the report lists company-specific R&D pipelines of coagulation factors. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
  • Index
    • Coagulation Factor VIII
    • Coagulation Factor IX
    • Coagulation Factor VII
    • Von Willebrand Factor (vWF)
    • Fibrinogen
    • Coagulation Factors XI and X
    • Coagulation Factor XIII
    • Other Recombinant Coagulation Factors
    • Alternative ProCoagulants & Adjuncts
    • Gene Therapy of Hemophilia
    • Topical Fibrinogen and Thrombin Products
    • Topical Thrombin Products
    • Alternative Topical Hemostats
    • Prothrombin Complex Concentrates
    • Corporate Coagulation Factor Product and R&D Pipelines
    • About La Merie
  • Corporate Coagulation Factor Product and R&D Pipelines
    • Abraxis Biosciences
    • Amsterdam Molecular Therapeutics
    • Amunix
    • Angiotech Pharmaceuticals
    • Apitope
    • Arecor
    • Asklepios Biopharmaceutical
    • Baxter
    • Bayer Schering Pharma
    • Bio Products Laboratory (BPL)
    • Biogen Idec
    • Biotest
    • Catalyst Biosciences
    • China Biologic Products
    • CSL
    • Ethicon (J&J)
    • Fresenius Kabi
    • Green Cross
    • Grifols
    • GTC Biotherapeutics (subsidiary of LFB)
    • Haemostatix
    • Hanmi Pharmaceutical Co
    • Hualan Biologic Engineering
    • Inspiration Biopharmaceuticals
    • Intas Biopharmaceuticals
    • Ipsen
    • Kaketsuken
    • Kamada
    • Kedrion
    • King Pharmaceuticals (to be acquired by Pfizer)
    • Lentigen
    • LFB
    • Lipoxen
    • Mochida Pharmaceutical
    • National Bioproducts Institute (NBI)
    • Novo Nordisk
    • Nycomed
    • Octapharma
    • Orthovita
    • Pain Therapeutics
    • Pfizer (acquired Wyeth)
    • Pharming
    • ProFibrix
    • PROLOR Biotech
    • Recoly
    • Sanquin
    • Shanghai RAAS
    • SK Chemicals
    • Swedish Orphan Biovitrum
    • Talecris Biotherapeutics
    • Thermogenesis
    • Thrombotargets
    • VIRxSYS
    • Vivostat
    • Zymogenetics
+44 20 8816 8548

Ask a question about Coagulation Factors

Enter the characters you see in the picture below